Wu Q, Reith M E, Kuhar M J, Carroll F I, Garris P A
Cellular and Integrative Physiology Section, Department of Biological Sciences, Illinois State University, Normal, Illinois 61790-4120, USA.
J Neurosci. 2001 Aug 15;21(16):6338-47. doi: 10.1523/JNEUROSCI.21-16-06338.2001.
In vivo voltammetry was used to investigate the preferential increase of extracellular dopamine in the nucleus accumbens relative to the caudate-putamen after systemic cocaine administration. In the first part of this study, cocaine (40 mg/kg, i.p.) was compared with two other blockers of dopamine uptake, nomifensine (10 mg/kg, i.p.) and 3beta-(p-chlorophenyl)tropan-2beta-carboxylic acid p-isothiocyanatophenylmethyl ester hydrochloride (RTI-76; 100 nmol, i.c.v.), to assess whether the inhibitory mechanism of cocaine differed in the two regions. All three drugs robustly increased electrically evoked levels of dopamine, and cocaine elevated dopamine signals to a greater extent in the nucleus accumbens. However, kinetic analysis of the evoked dopamine signals indicated that cocaine and nomifensine increased the K(m) for dopamine uptake whereas the dominant effect of RTI-76 was a decrease in V(max). Under the present in vivo conditions, therefore, cocaine is a competitive inhibitor of dopamine uptake in both the nucleus accumbens and caudate-putamen. Whether the preferential effect of cocaine was mediated by regional differences in the presynaptic control of extracellular DA that are described by rates for DA uptake and release was examined next by a correlation analysis. The lower rates for dopamine release and uptake measured in the nucleus accumbens were found to underlie the preferential increase in extracellular dopamine after cocaine. This relationship explains the paradox that cocaine more effectively increases accumbal dopamine despite identical effects on the dopamine transporter in the two regions. The mechanism proposed for the preferential actions of cocaine may also mediate the differential effects of psychostimulant in extrastriatal regions and other uptake inhibitors in the striatum.
采用体内伏安法研究全身给予可卡因后,伏隔核细胞外多巴胺相对于尾状核-壳核优先增加的情况。在本研究的第一部分,将可卡因(40毫克/千克,腹腔注射)与另外两种多巴胺摄取阻滞剂诺米芬辛(10毫克/千克,腹腔注射)和3β-(对氯苯基)托烷-2β-羧酸对异硫氰酸苯甲基酯盐酸盐(RTI-76;100纳摩尔,脑室内注射)进行比较,以评估可卡因在这两个区域的抑制机制是否不同。所有三种药物均能显著提高电诱发的多巴胺水平,且可卡因在伏隔核中使多巴胺信号升高的程度更大。然而,对诱发的多巴胺信号进行动力学分析表明,可卡因和诺米芬辛增加了多巴胺摄取的米氏常数(K(m)),而RTI-76的主要作用是使最大反应速度(V(max))降低。因此,在目前的体内条件下,可卡因在伏隔核和尾状核-壳核中均为多巴胺摄取的竞争性抑制剂。接下来通过相关性分析研究了可卡因的优先作用是否由细胞外多巴胺突触前控制的区域差异介导,这种差异由多巴胺摄取和释放速率来描述。结果发现,伏隔核中较低的多巴胺释放和摄取速率是可卡因后细胞外多巴胺优先增加的基础。这种关系解释了一个矛盾现象,即尽管可卡因对这两个区域的多巴胺转运体有相同的作用,但它能更有效地增加伏隔核多巴胺。所提出的可卡因优先作用机制也可能介导了精神兴奋剂在纹状体以外区域的不同作用以及纹状体中其他摄取抑制剂的作用。